Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Ado-Trastuzumab Emtansine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Stomach Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Pleuropulmonary blastoma 1 Patient Preference 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 HER2-positive Breast Cancer 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 39 fludarabine phosphate 38 fludarabine 35 Imatinib Mesylate 33 Whole-Body Irradiation 31 Mycophenolic Acid 29 nilotinib 28 Tacrolimus 23 Busulfan 20 Cyclosporine 16 thymoglobulin 15 Melphalan 14 Granulocyte Colony-Stimulating Factor 14 Dasatinib 14 Antilymphocyte Serum 14 Thiotepa 12 Peripheral Blood Stem Cell Transplantation 12 Filgrastim 11 bosutinib 10 Stem Cell Transplantation 10 Methotrexate 10 ponatinib 8 Cord Blood Stem Cell Transplantation 8 sargramostim 7 Rituximab 7 Cytarabine 7 Cyclosporins 7 Clofarabine 6 plerixafor 5 Sirolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡